American Journal of Cardiology
Volume 104, Issue 3 , Pages 327-332 , 1 August 2009

Usefulness of Intra-Aortic Balloon Pump Counterpulsation in Patients With Cardiogenic Shock from Acute Myocardial Infarction

  • Jin M. Cheng, MSc

      Affiliations

    • Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Suzanne D.A. Valk, MD

      Affiliations

    • Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Corstiaan A. den Uil, MD

      Affiliations

    • Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel: (+31) 10-703-5019; fax: (+31) 10-703-2890
  • ,
  • Martin van der Ent, MD, PhD

      Affiliations

    • Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Wim K. Lagrand, MD, PhD

      Affiliations

    • Department of Intensive Care Medicine, Academic Medical Center, Amsterdam, The Netherlands
  • ,
  • Meike van de Sande, MD

      Affiliations

    • Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Ron T. van Domburg, PhD

      Affiliations

    • Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Maarten L. Simoons, MD, PhD

      Affiliations

    • Thoraxcenter, Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands

Received 28 January 2009 ,Revised 24 March 2009 ,Accepted 24 March 2009.

References 

  1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology (Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)). Eur Heart J. 2008;29:2388–2442
  2. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009;119:1211–1219
  3. Bengtson JR, Kaplan AJ, Pieper KS, Wildermann NM, Mark DB, Pryor DB, et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol. 1992;20:1482–1489
  4. Anderson RD, Ohman EM, Holmes DR, Col I, Stebbins AL, Bates ER, et al. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I study: Global Utilization of Streptokinase and t-PA for Occluded coronary arteries. J Am Coll Cardiol. 1997;30:708–715
  5. Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. J Am Coll Cardiol. 2000;36:1123–1129
  6. Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141:933–939
  7. Ohman EM, Nanas J, Stomel RJ, Leesar MA, Nielsen DW, O'Dea D, et al. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS trial. J Thromb Thrombolysis. 2005;19:33–39
  8. Sjauw KD, Engstrom AE, Vis MM, van der Schaaf RJ, Baan J, Koch KT, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?. Eur Heart J. 2009;30:459–468
  9. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:384–416
  10. Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, et al. Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK trial Registry: SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. J Am Coll Cardiol. 2000;36:1063–1070
  11. Chen EW, Canto JG, Parsons LS, Peterson ED, Littrell KA, Every NR, et al. Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock. Circulation. 2003;108:951–957
  12. Singh M, White J, Hasdai D, Hodgson PK, Berger PB, Topol EJ, et al. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial. J Am Coll Cardiol. 2007;50:1752–1758
  13. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock (SHOCK Investigators. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK). N Engl J Med. 1999;341:625–634
  14. Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295:2511–2515
  15. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294:448–454
  16. Ferguson JJ, Cohen M, Freedman RJ, Stone GW, Miller MF, Joseph DL, et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol. 2001;38:1456–1462
  17. Azeem T, Stephens-Lloyd A, Spyt T, Hartshorne R, Gershlick AH. Intra-aortic balloon counterpulsation: variations in use and complications. Int J Cardiol. 2004;94:255–259
  18. Eltchaninoff H, Dimas AP, Whitlow PL. Complications associated with percutaneous placement and use of intraaortic balloon counterpulsation. Am J Cardiol. 1993;71:328–332
  19. Scholz KH, von Ragab S, von zur Muhlen F, Schroder T, Werner GS, Mindel L, et al. Complications of intra-aortic balloon counterpulsation: the role of catheter size and duration of support in a multivariate analysis of risk. Eur Heart J. 1998;19:458–465

PII: S0002-9149(09)00812-1

doi: 10.1016/j.amjcard.2009.03.050

American Journal of Cardiology
Volume 104, Issue 3 , Pages 327-332 , 1 August 2009